• Cibus Inc CBUS.OQ reported a quarterly adjusted loss of 74 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $-1.12. The mean expectation of two analysts for the quarter was for a loss of 66 cents per share.

• Revenue rose 89.7% to $1.03 million from a year ago; analysts expected $1.14 million.

• Cibus Inc's reported EPS for the quarter was a loss of $1.34​.

• The company reported a quarterly loss of $46.89 million.

• Cibus Inc shares had risen by 33.7% this quarter and lost 10.1% so far this year.

FORECAST CHANGES

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for Cibus Inc is $20.75

This summary was machine generated from LSEG data May 8 at 11:06 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)